COST-EFFECTIVENESS OF A RENAL HEALTH PROGRAM IN PATIENTS WITH HYPERTENSIVE AND/OR DIABETES INDUCED CHRONIC KIDNEY DISEASE

被引:0
|
作者
Rosselli, D. [1 ]
DeAntonio, R. [2 ]
Calderon, C. [1 ]
Sanabria, M. [3 ]
机构
[1] Independiente, Bogota, DC, Colombia
[2] Independent, Bogota, Colombia
[3] Baxter Colombia, Bogota, Cundinamarca, Colombia
关键词
D O I
10.1016/S1098-3015(10)74062-6
中图分类号
F [经济];
学科分类号
02 ;
摘要
引用
收藏
页码:A200 / A200
页数:1
相关论文
共 50 条
  • [41] Cost-effectiveness analysis of dapagliflozin for people with chronic kidney disease in Malaysia
    Lim, Soo Kun
    Lee, Shaun Wen Huey
    PLOS ONE, 2024, 19 (03):
  • [42] THE COST-EFFECTIVENESS OF SCREENING FOR MICROALBUMINURIA: A SIMULATION MODEL FOR CHRONIC KIDNEY DISEASE
    Hoerger, Thomas
    Witterborn, John
    Segel, Joel
    Burrows, Nilka Rios
    Eggers, Paul
    Pavkov, Meda
    Jordan, Regina
    Schoolwerth, Anton C.
    Willams, Desmond
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2009, 53 (04) : A42 - A42
  • [43] Cost-effectiveness of lipid lowering with statins and ezetimibe in chronic kidney disease
    Schlackow, Iryna
    Kent, Seamus
    Herrington, William
    Emberson, Jonathan
    Haynes, Richard
    Reith, Christina
    Collins, Rory
    Landray, Martin J.
    Gray, Alastair
    Baigent, Colin
    Mihaylova, Borislava
    Baxter, A.
    Young, A.
    Hill, M.
    Knott, C.
    Cass, A.
    Feldt-Rasmussen, B.
    Fellstrom, B.
    Grobbee, D. E.
    Gronhagen-Riska, C.
    Haas, M.
    Holdaas, H.
    Hooi, L. S.
    Jiang, L.
    Kasiske, B.
    Krairittichai, U.
    Levin, A.
    Massy, Z. A.
    Tesar, V.
    Walker, R.
    Wanner, C.
    Wheeler, D. C.
    Wiecek, A.
    Dasgupta, T.
    Herrington, W.
    Lewis, D.
    Mafham, M.
    Majoni, W.
    Reith, C.
    Emberson, J.
    Parish, S.
    Simpson, D.
    Strony, J.
    Musliner, T.
    Agodoa, L.
    Armitage, J.
    Chen, Z.
    Craig, J.
    de Zeeuw, D.
    Gaziano, J. M.
    KIDNEY INTERNATIONAL, 2019, 96 (01) : 170 - 179
  • [44] Cost-Effectiveness of Dapagliflozin for Non-diabetic Chronic Kidney Disease
    Rebecca L. Tisdale
    Marika M. Cusick
    Kelly Zhang Aluri
    Thomas J. Handley
    Alice Kate Cummings Joyner
    Joshua A. Salomon
    Glenn M. Chertow
    Jeremy D. Goldhaber-Fiebert
    Douglas K. Owens
    Journal of General Internal Medicine, 2022, 37 : 3380 - 3387
  • [45] Projecting the potential cost-effectiveness of dapagliflozin for chronic kidney disease in Kuwait
    Swidan, Ahmed
    Elsisi, Gihan Hamdy
    Ibrahim, Mohamed M. M.
    Aljazzar, Mohammad
    Sallam, Hossameldin Tawfik
    JOURNAL OF MEDICAL ECONOMICS, 2023, 26 (01) : 271 - 282
  • [46] Use of surrogacy for women with chronic kidney disease: a cost-effectiveness analysis
    Farwell, Jennifer
    Wyatt, Solange
    Rueda, Jose
    Emerson, Jenna
    Page, Jessica
    Fowler, Jessica
    Allen, Allison
    Caughey, Aaron
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2013, 208 (01) : S153 - S153
  • [47] Cost-Effectiveness of Administering Oral Adsorbent AST-120 to Patients with Diabetes and Advance-Stage Chronic Kidney Disease
    Hayashino, Yasuaki
    Fukuhara, Shunichi
    Akizawa, Tadao
    Asano, Yasushi
    Wakita, Takafumi
    Onishi, Yoshihiro
    Kurokawa, Kiyoshi
    DIABETES, 2010, 59 : A253 - A253
  • [48] Cost-Effectiveness Analysis of Finerenone for Treatment of Chronic Kidney Disease in Patients with Type 2 Diabetes from Japanese Payer Perspective
    Igarashi, Ataru
    Ohara, Kenichi
    Matsuda, Hiroyuki
    Morii, Junko
    Jagannathan, Suchitra
    Filomeno, Ronald
    ADVANCES IN THERAPY, 2025, 42 (02) : 995 - 1008
  • [49] COST-EFFECTIVENESS OF A DIGITAL DIABETES PREVENTION PROGRAM (DDPP) IN PREDIABETIC PATIENTS
    Park, S.
    Ward, T.
    Sudimack, A.
    Cox, S.
    Ballreich, J.
    VALUE IN HEALTH, 2022, 25 (12) : S86 - S86
  • [50] Cost-effectiveness of administering oral adsorbent AST-120 to patients with diabetes and advance-stage chronic kidney disease
    Hayashino, Yasuaki
    Fukuhara, Shunichi
    Akizawa, Tadao
    Asano, Yasushi
    Wakita, Takafumi
    Onishi, Yoshihiro
    Kurokawa, Kiyoshi
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2010, 90 (02) : 154 - 159